JP2019520365A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520365A5 JP2019520365A5 JP2018568285A JP2018568285A JP2019520365A5 JP 2019520365 A5 JP2019520365 A5 JP 2019520365A5 JP 2018568285 A JP2018568285 A JP 2018568285A JP 2018568285 A JP2018568285 A JP 2018568285A JP 2019520365 A5 JP2019520365 A5 JP 2019520365A5
- Authority
- JP
- Japan
- Prior art keywords
- stem cells
- pharmaceutical composition
- exosomes
- thrombin
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2016-0083703 | 2016-07-01 | ||
| KR20160083703 | 2016-07-01 | ||
| KR10-2017-0080366 | 2017-06-26 | ||
| KR1020170080366A KR101860266B1 (ko) | 2016-07-01 | 2017-06-26 | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 피부상처 치료용 조성물 |
| PCT/KR2017/006776 WO2018004237A1 (ko) | 2016-07-01 | 2017-06-27 | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 피부상처 치료용 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019520365A JP2019520365A (ja) | 2019-07-18 |
| JP2019520365A5 true JP2019520365A5 (https=) | 2020-04-09 |
| JP6826135B2 JP6826135B2 (ja) | 2021-02-03 |
Family
ID=60998515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018568285A Active JP6826135B2 (ja) | 2016-07-01 | 2017-06-27 | トロンビン処理幹細胞に由来するエクソソームを含む皮膚傷治療用組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12239695B2 (https=) |
| EP (1) | EP3479831B1 (https=) |
| JP (1) | JP6826135B2 (https=) |
| KR (1) | KR101860266B1 (https=) |
| CN (1) | CN109641013B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101973284B1 (ko) * | 2017-01-16 | 2019-04-29 | 사회복지법인 삼성생명공익재단 | 신생아 ｈｉｅ 치료용 조성물 |
| WO2020022541A1 (ko) | 2018-07-27 | 2020-01-30 | 주식회사 엑소스템텍 | 엑소좀을 유효성분으로 포함하는 급성 간부전의 예방 또는 치료용 조성물 |
| KR102278102B1 (ko) | 2018-07-27 | 2021-07-15 | 주식회사 엑소스템텍 | 엑소좀을 유효성분으로 포함하는 급성 간질환의 예방 또는 치료용 조성물 |
| KR102323056B1 (ko) * | 2019-05-02 | 2021-11-09 | 에스씨엠생명과학 주식회사 | hPL 함유 배지에서 배양된 중간엽 줄기세포의 배양액을 포함하는 화장료 조성물 |
| KR102159394B1 (ko) * | 2019-10-04 | 2020-09-24 | (주)에스디생명공학 | 바다제비집에서 유래된 엑소좀을 유효성분으로 포함하는 피부 상태 개선용 조성물 |
| US12491212B2 (en) | 2019-11-12 | 2025-12-09 | Brexogen Inc. | Composition for preventing or treating renal diseases, comprising exosomes derived from precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells |
| JP2021116228A (ja) * | 2020-01-22 | 2021-08-10 | 医薬資源研究所株式会社 | 抗酸化ストレス剤、化粧品、および医薬品 |
| US12077780B2 (en) | 2020-02-14 | 2024-09-03 | Allergan Sales, Llc | Conditioned medium from cells cultured under hypoxic conditions and uses thereof |
| KR20210127510A (ko) * | 2020-04-14 | 2021-10-22 | 사회복지법인 삼성생명공익재단 | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 당뇨병성 피부질환 예방 또는 치료용 조성물 |
| CN111888379A (zh) * | 2020-08-17 | 2020-11-06 | 济宁医学院附属医院 | 干细胞来源的微囊泡在制备修复瘢痕的制剂中的应用 |
| EP4252761A4 (en) * | 2020-11-26 | 2024-06-05 | Samsung Life Public Welfare Foundation | COMPOSITION FOR THE TREATMENT OF INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-PROCESSED STEM CELLS |
| JP2024528547A (ja) * | 2021-06-30 | 2024-07-30 | プリモリス セラピューティクス カンパニー リミテッド | アンチセンスオリゴヌクレオチドに基づく薬物が搭載された細胞由来の自然又は人工ナノベシクルを含有する薬学組成物 |
| CN114904043B (zh) * | 2022-04-28 | 2023-07-21 | 深圳市儿童医院 | 复合水凝胶及其制备方法和应用 |
| CN120513095A (zh) * | 2022-11-25 | 2025-08-19 | 希望细胞疗法株式会社 | vMSC的分泌组及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5911874B2 (ja) * | 2010-10-18 | 2016-04-27 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | 発毛を促進又は増強するためのエキソソームの使用 |
| EP2850178A4 (en) | 2012-05-18 | 2015-10-28 | Agency Science Tech & Res | EXOSOMES OF MESHCHYMIC STROKE CELL OF UMBILICAL CORD |
| KR20140066456A (ko) | 2012-11-23 | 2014-06-02 | 호서대학교 산학협력단 | 피부각질세포 유래 엑소좀, 엑소좀을 포함하는 분획물의 피부재생용 화장품 조성물 및 이의 용도 |
| GB201317889D0 (en) | 2013-10-09 | 2013-11-20 | Reneuron Ltd | Product and use |
| KR101662405B1 (ko) * | 2013-12-12 | 2016-10-05 | 사회복지법인 삼성생명공익재단 | 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌혈관 질환 치료용 약학적 조성물 |
| US9919011B2 (en) * | 2014-03-18 | 2018-03-20 | Samsung Life Public Welfare Foundation | Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome |
| CN105477016A (zh) * | 2015-11-13 | 2016-04-13 | 中国人民解放军第二军医大学 | 人间充质干细胞来源的外泌体在抗组织纤维化及瘢痕形成中的应用 |
-
2017
- 2017-06-26 KR KR1020170080366A patent/KR101860266B1/ko active Active
- 2017-06-27 US US16/314,725 patent/US12239695B2/en active Active
- 2017-06-27 JP JP2018568285A patent/JP6826135B2/ja active Active
- 2017-06-27 CN CN201780047575.0A patent/CN109641013B/zh active Active
- 2017-06-27 EP EP17820513.4A patent/EP3479831B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019520365A5 (https=) | ||
| RU2759508C1 (ru) | Композиция, включающая экзосому, полученную из стволовых клеток, для индукции адипогенной дифференцировки, регенерации жировой ткани, отбеливания кожи или коррекции морщин | |
| US10980837B2 (en) | Lyophilized platelet lysates | |
| da Silva et al. | Stem cell-containing hyaluronic acid-based spongy hydrogels for integrated diabetic wound healing | |
| Barakat et al. | Limited treatment options for diabetic wounds: barriers to clinical translation despite therapeutic success in murine models | |
| US12239695B2 (en) | Composition comprising thrombin-treated stem cell-derived exosome for treating skin wound | |
| Zhan et al. | Macrophage-derived microvesicles promote proliferation and migration of Schwann cell on peripheral nerve repair | |
| CN109069541B (zh) | 包含来源于凝血酶处理干细胞的外泌体的慢性肺病的治疗用组合物 | |
| TWI857807B (zh) | 含有粒線體之組合物及其用於作為皮膚纖維母細胞活性促進劑之用途 | |
| RU2015137965A (ru) | Сывороточная фракция обогащенного тромбоцитами фибрина | |
| Da Silva et al. | The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives | |
| Wang et al. | Diverse-origin exosomes therapeutic strategies for diabetic wound healing | |
| JP2023105066A (ja) | 組織治癒剤 | |
| Wang et al. | Mesenchymal stem cell-derived exosomes hold promise in the treatment of diabetic foot ulcers | |
| TW201922276A (zh) | 間葉系幹細胞引誘劑 | |
| Mester et al. | Stem cell therapy in wound healing | |
| Mörschbächer et al. | Treatment of dilated cardiomyopathy in rabbits with mesenchymal stem cell transplantation and platelet-rich plasma | |
| EP2431046B1 (en) | Use of olive leaf extracts in a pharmaceutical composition for inducing angiogenesis and vasculogenesis | |
| JP2015061536A5 (https=) | ||
| JP5251873B2 (ja) | 脂肪組織細胞画分の照射後組織再生への使用 | |
| Trivisonno et al. | Adipose tissue: from energy reservoir to a source of cells for epithelial tissue engineering | |
| Aidarova et al. | Applications of cord blood cells in neurology | |
| AlAdwan et al. | Cell-free therapeutics for non-healing wounds: role of MSC-derived exosomes in macrophage polarization, angiogenesis, and fibroblast-mediated ECM remodeling-bridging preclinical insights to clinical translation | |
| Chandra et al. | Role of the Immune System in Wound Healing and Strategies to Modulate Immune Responses to Promote Wound Healing | |
| KR102633660B1 (ko) | 효능이 증진된 줄기세포 유래 세포외소포를 포함하는 상처 치료용 조성물 |